Procopio Emanuele E

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Hepatectomy versus Chemotherapy for Resectable Colorectal Liver Metastases in Progression after Perioperative Chemotherapy: Expanding the Boundaries of the Curative Intent.

Not available

S-EPMC9913571 | biostudies-literature

Microarray expression profiling of NKT and MAIT subsets in different organs of B6-MAIT/CAST mice.

MAIT cells (MAITs) represent an abundant T lymphocyte subset with unique specificity for microbial metabolites presented by the MHC-1b molecule, MR1. MAIT conservation along evolution indicates important, non-redundant functions, but their low frequency in mice has hampered their detailed characteri...

ORGANISM(S): Mus musculus

2018-12-03 | E-MTAB-7133 | biostudies-arrayexpress

RNA-seq expression profiling of humain MAIT cells in blood and liver as compared to mainstream TCD4+ and TCD8+ cells.

At variance with what is observed in mice, no distinct MAIT1 or MAIT17 subsets exist in human blood, as all MAIT cells express a variety of transcription factors such as Rorgt, Tbet, Eomes and Helios. However, they are also found in tissues in which they have specific effector functions. To determin...

ORGANISM(S): Homo sapiens

2018-12-03 | E-MTAB-7143 | biostudies-arrayexpress

Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication.

Not available

S-EPMC10561686 | biostudies-literature

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.

Not available

S-EPMC9524042 | biostudies-literature

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.

Not available

S-EPMC11219688 | biostudies-literature

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).